Relay Therapeutics, Inc. (RLAY) on GreekSoup https://greeksoup.ai/stocks/us/rlay/ Every dated entry in the public record on Relay Therapeutics, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 Relay Therapeutics, Inc.: short interest 44,026,826 shares at the 15 October 2026 settlement, 16.00 days to coverhttps://greeksoup.ai/stocks/us/rlay/short-interest/us:RLAY:short-interest:2026-10-15:08a6bd075dThu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: Patel Sanjiv (President and CEO) sold 48,199 shares (under a trading plan set in advance) at $18.10 on 7 October 2026, $872,402https://greeksoup.ai/stocks/us/rlay/insiders/us:RLAY:insider:2026-10-08:0d8bd4cdcdThu, 08 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: Catinazzo Thomas (Chief Financial Officer) sold 17,511 shares (under a trading plan set in advance) at $18.58 on 6 October 2026, $325,354https://greeksoup.ai/stocks/us/rlay/insiders/us:RLAY:insider:2026-10-08:d786a5762dThu, 08 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: Catinazzo Thomas (Chief Financial Officer) sold 206 shares (under a trading plan set in advance) at $19.26 on 6 October 2026, $3,968https://greeksoup.ai/stocks/us/rlay/insiders/us:RLAY:insider:2026-10-08:4937ff5b67Thu, 08 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: Form 144, SANJIV PATEL plans to sell 96,401 shares worth $1.8 million around 7 October 2026https://greeksoup.ai/stocks/us/rlay/planned-sales/us:RLAY:planned-sale:2026-10-07:c2f8ff4a8bWed, 07 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: Form 144, THOMAS CATINAZZO plans to sell 93,153 shares worth $1.8 million around 6 October 2026https://greeksoup.ai/stocks/us/rlay/planned-sales/us:RLAY:planned-sale:2026-10-06:049df3687aTue, 06 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: short interest 46,746,942 shares at the 30 September 2026 settlement, 12.59 days to coverhttps://greeksoup.ai/stocks/us/rlay/short-interest/us:RLAY:short-interest:2026-09-30:9df0e39936Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: short interest 44,487,428 shares at the 15 September 2026 settlement, 14.22 days to coverhttps://greeksoup.ai/stocks/us/rlay/short-interest/us:RLAY:short-interest:2026-09-15:5aa5fa2490Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: Bergstrom Donald A (President, R&D) sold 8,530 shares (under a trading plan set in advance) at $18.97 on 8 September 2026, $161,814https://greeksoup.ai/stocks/us/rlay/insiders/us:RLAY:insider:2026-09-09:140e739f2dWed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: Catinazzo Thomas (Chief Financial Officer) sold 17,717 shares (under a trading plan set in advance) at $18.94 on 8 September 2026, $335,560https://greeksoup.ai/stocks/us/rlay/insiders/us:RLAY:insider:2026-09-09:2b076e7837Wed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: Patel Sanjiv (President and CEO) sold 48,199 shares (under a trading plan set in advance) at $18.94 on 8 September 2026, $912,889https://greeksoup.ai/stocks/us/rlay/insiders/us:RLAY:insider:2026-09-09:7b149764f6Wed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: short interest 43,550,416 shares at the 31 August 2026 settlement, 16.73 days to coverhttps://greeksoup.ai/stocks/us/rlay/short-interest/us:RLAY:short-interest:2026-08-31:75c84a0481Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: Rahmer Peter (See remarks) sold 4,508 shares (under a trading plan set in advance) at $20.03 on 26 August 2026, $90,295https://greeksoup.ai/stocks/us/rlay/insiders/us:RLAY:insider:2026-08-28:b2066095b7Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: Svf Pauling (Cayman) Ltd (10% owner), see footnote, sold 6,000,000 shares at $19.40 on 25 August 2026, $116.4 millionhttps://greeksoup.ai/stocks/us/rlay/insiders/us:RLAY:insider:2026-08-28:78e7af57cbFri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: Form 144, PETER RAHMER plans to sell 50,000 shares worth $1.0 million around 26 August 2026https://greeksoup.ai/stocks/us/rlay/planned-sales/us:RLAY:planned-sale:2026-08-26:7de597edfbWed, 26 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: Form 144, SVF Pauling (Cayman) Ltd plans to sell 6,000,000 shares worth $123.4 million around 25 August 2026https://greeksoup.ai/stocks/us/rlay/planned-sales/us:RLAY:planned-sale:2026-08-25:deaefea68cTue, 25 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: Patel Sanjiv (President and CEO) sold 48,199 shares (under a trading plan set in advance) at $20.33 on 17 August 2026, $979,886https://greeksoup.ai/stocks/us/rlay/insiders/us:RLAY:insider:2026-08-18:c7902a822bTue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: Catinazzo Thomas (Chief Financial Officer) sold 17,717 shares (under a trading plan set in advance) at $19.74 on 14 August 2026, $349,734https://greeksoup.ai/stocks/us/rlay/insiders/us:RLAY:insider:2026-08-18:606b717c75Tue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: Schedule 13G/A filed by Commodore Capital LP, 5.5% of the classhttps://greeksoup.ai/stocks/us/rlay/holders/us:RLAY:schedule-13:2026-08-14:66f2159df4Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: short interest 41,359,202 shares at the 14 August 2026 settlement, 21.59 days to coverhttps://greeksoup.ai/stocks/us/rlay/short-interest/us:RLAY:short-interest:2026-08-14:8cde852facFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: Schedule 13G/A filed by Perceptive Advisors LLC, 6.4% of the classhttps://greeksoup.ai/stocks/us/rlay/holders/us:RLAY:schedule-13:2026-08-10:98f3370a97Mon, 10 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: Schedule 13G/A filed by FMR LLC, 10.0% of the classhttps://greeksoup.ai/stocks/us/rlay/holders/us:RLAY:schedule-13:2026-08-07:7a7a653ed8Fri, 07 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc. Q2 FY2026 results: revenue $350,000, net income -$84 millionhttps://greeksoup.ai/stocks/us/rlay/results/fy2026-q2/us:RLAY:result:2026-08-06:a67d28d504Thu, 06 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/rlay/filings/us:RLAY:filing:2026-08-06:6c4de4bedaThu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc. filed 8-K: material agreement, results of operationshttps://greeksoup.ai/stocks/us/rlay/filings/us:RLAY:filing:2026-08-06:7082b310f7Thu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: Schedule 13G filed by FMR LLC, 9.4% of the classhttps://greeksoup.ai/stocks/us/rlay/holders/us:RLAY:schedule-13:2026-08-06:096a8451e3Thu, 06 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: Form 144, SEKAR KATHIRESAN plans to sell 42,225 shares worth $826,466 around 4 August 2026https://greeksoup.ai/stocks/us/rlay/planned-sales/us:RLAY:planned-sale:2026-08-04:16a0097fbaTue, 04 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: Form 144, SEKAR KATHIRESAN plans to sell 30,000 shares worth $563,553 around 31 July 2026https://greeksoup.ai/stocks/us/rlay/planned-sales/us:RLAY:planned-sale:2026-07-31:c7582d48ceFri, 31 Jul 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: short interest 40,250,044 shares at the 31 July 2026 settlement, 17.41 days to coverhttps://greeksoup.ai/stocks/us/rlay/short-interest/us:RLAY:short-interest:2026-07-31:a84059f3a5Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: Catinazzo Thomas (Chief Financial Officer) sold 1,459 shares at $18.61 on 28 July 2026, $27,152https://greeksoup.ai/stocks/us/rlay/insiders/us:RLAY:insider:2026-07-30:954d31474dThu, 30 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: Rahmer Peter (See remarks) sold 748 shares at $18.61 on 28 July 2026, $13,920https://greeksoup.ai/stocks/us/rlay/insiders/us:RLAY:insider:2026-07-30:e9c66df2e4Thu, 30 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Relay Therapeutics, Inc.: Bergstrom Donald A (President, R&D) sold 2,237 shares at $18.61 on 28 July 2026, $41,631https://greeksoup.ai/stocks/us/rlay/insiders/us:RLAY:insider:2026-07-30:0172d37400Thu, 30 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]>